GNFTY
Genfit S.A.
No data for this timeframe.
Vol
Inst. Holders2 funds
Inst. Value$97.2K
Inst. Activity0 buys / 1 sells
Recent Activity
Inst.
MORGAN STANLEY — EXIT
0 shares ($0.00)
Inst.
MORGAN STANLEY — TRIM
20,120 shares ($76.5K)
Price Targets
Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$9.16 (Sep 2025)
Current $8.95
Low $6.97
Median $7.95
High $12.56
3 analysts
$6.97
$12.56
Analyst Ratings
7Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 24, 2025 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next FY | $-0.22 | $-0.53 — $0.09 | -19% YoY | 2 |
| Current FY | $-0.18 | $-0.23 — $-0.14 | -717% YoY | 2 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $76.5K | EXIT |
| UBS Group AG | $20.7K | ADD |
2 institutional holders with $97.2K total value (25,569 shares) as of 2025-Q3. Top holders: MORGAN, UBS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 20,120 | $76.5K | 78.7% | EXIT -100.0% |
| 2 | UBS Group AG | 5,449 | $20.7K | 21.3% | ADD +33.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | EXIT | 20,120 | 0 | -100.0% | $0.00 | 2025-Q4 |
| MORGAN STANLEY | TRIM | 27,420 | 20,120 | -26.6% | $76.5K | 2025-Q3 |
| UBS Group AG | ADD | 4,081 | 5,449 | +33.5% | $20.7K | 2025-Q3 |
| UBS Group AG | ADD | 3,118 | 4,081 | +30.9% | $15.2K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 17 | 1 | -94.1% | $4.00 | 2025-Q2 |
| MORGAN STANLEY | TRIM | 34,720 | 25,520 | -26.5% | $87.3K | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 12,331 | — | $44.3K | 2025-Q1 |
| MORGAN STANLEY | ADD | 25,020 | 34,720 | +38.8% | $129.0K | 2024-Q4 |
| UBS Group AG | NEW | — | 3,048 | — | $11.3K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Sep 2025): 92% buy across 12 analysts — 7 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$9.16 mean target (Sep 2025)
$6.97 Low
$12.56 High
| Metric | Value |
|---|---|
| Current Price | $8.95 |
| Target Low | $6.97 |
| Target Mean | $9.16 |
| Target Median | $7.95 |
| Target High | $12.56 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY 2026-12-31 |
$-0.22 | $-0.53 | $0.09 | -18.9% | +0.0% | 2↑ 0↓ | $0.1B | 10.3% | 2 |
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$-0.18 | $-0.23 | $-0.14 | -716.7% | +0.0% | 0↑ 1↓ | $0.1B | -2.4% | 2 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Sep 24, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 7 | 4 | 1 | 0 | 0 | 92% | |
| May 1, 2026 | 7 | 4 | 1 | 0 | 0 | 92% | |
| Apr 1, 2026 | 7 | 4 | 1 | 0 | 0 | 92% | |
| Mar 1, 2026 | 7 | 4 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 7 | 4 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 7 | 4 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.